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SUMMARY
We have studied the effects of hypocapnia on
cerebrovascular changes in two MAC-equivalent
anaesthetic regimens, using the transcranial
Doppler technique as an index of cerebral blood
flow (CBF) in 24 healthy ASA I patients undergoing
spinal surgery. Eight of the patients were subjected
to carbon dioxide reactivity challenges in the awake
state. Before surgery, the other 16 patients received,
in random order, either 1.15% isof/urane in oxygen
or 0.5% isof/urane with 70% nitrous oxide. Carbon
dioxide reactivity was calculated for each group as
the increase in flow velocity per kPa change in
P?co2 (cm s~1 kPa~'). It was significantly greater for
the isof/urane group (14.09 (SD 2.44) cm s~1 kPa'1)
and significantly less for the isoflurane-nitrous
oxide group (7.95 (132) cm s~' kPa~') compared
with the awake group (11.24 (0.95) cm s~1 kPa~7).
We conclude that cerebrovascular responsiveness
to changes in arterial carbon dioxide concentration
is influenced markedly by the anaesthetic pro-
cedure. Hyperventilation is more likely to affect
CBF during isof/urane anaesthesia than during an
MAC-equivalent isoflurane-nitrous oxide anaes-
thesia. (Br. J. Anaesth. 1993; 7 1 : 272-276)
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All volatile anaesthetics have cerebral vasodilator
properties that produce a dose-dependent increase in
cerebral blood flow (CBF) [1]. Administration may
cause potentially dangerous increases in CBF, and
hence intracranial pressure, in some neurosurgical
patients. However, these changes in CBF may be
attenuated effectively by controlled hyperventilation
[2]. In addition to hypocapnia, many clinicians use
volatile anaesthetics in combination with nitrous
oxide, thereby reducing the concentration of volatile
drug required.
Isoflurane is considered increasingly for neuro-
surgical anaesthesia because it has weaker cerebral
vasodilator properties than other halogenated an-
aesthetic agents [3-5]. In neuroanaesthesia, nitrous
oxide is used commonly in combination with iso-
flurane during moderate hypocapnia. Because hyper-
ventilation is an almost universal component of
neurosurgical anaesthesia, with or without nitrous
oxide, it is essential to understand the relationship
between CBF and arterial carbon dioxide concen-
tration during anaesthetic conditions. The present
study was designed to compare carbon dioxide
responsiveness during two anaesthetic regimens—
either isoflurane alone or an MAC-equivalent
isoflurane-nitrous oxide combination, with the
awake state. The anaesthetic-induced CBF changes
were assessed using a transcranial Doppler (TCD)
technique.
PATIENTS AND METHODS
We studied 24 ASA I patients (mean age 36 yr (range
24-54 yr); 14 male) undergoing elective spinal
surgery. No patient had signs or symptoms of
neurological or cerebrovascular disease. Informed
consent was obtained and the study was approved by
the Committee for Ethics in Human Research of our
institution. All patients had fasted for at least 8 h and
were unpremedicated. Monitors were used to record
ECG (Spacelabs), arterial pressure, non-invasive
(Spacelabs) and percutaneous oxygen saturation
(SpOi) (Nellcor 2500). A carbon dioxide analyser and
a multigas analyser (Nellcor 2500) were incorporated
in the breathing system to monitor end-tidal carbon
dioxide partial pressure (PE'CO,) and concentrations
of nitrous oxide and isoflurane.
Cerebral blood flow velocity was measured for
each subject both with and without carbon dioxide
challenge; all measurements were made before
surgery. Eight of the patients were subjected to
carbon dioxide reactivity measurements in the awake
state before induction of anaesthesia. The remaining
16 patients were allocated randomly to receive a
1-MAC anaesthetic gas concentration comprising
isoflurane alone or isoflurane and nitrous oxide.
Anaesthesia was induced with a single dose of
propofol 1 mg kg"1 and alfentanil 20 ug kg"1; vecur-
onium 0.1 mg mg"1 was given for neuromuscular
block. The lungs were ventilated for 4 min with
isoflurane in oxygen, the trachea intubated and
thereafter the lungs ventilated mechanically (Sulla
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TABLE I. Patient characteristics (mean (SD) [range]). No significant differences
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Awake Isoflurane
Isoflurane-
nitrous oxide
Age (yr)
Sex(M/F)
Weight (kg)
Haemoglobin concn
(g litre"1)
36 [24-^8]
5/3
71.6 (10.9) [56-88]
142.1 (6.7)
34 [24-^ 15]
5/3
74.6 (14.1) [52-88]
142.0(12.6)
38 [28-54]
4/4
69.5 (12.8) [52-88]
141.3(13.6)
808V) with a mixture of 30 % oxygen in air adjusted
to achieve PE'COI 5.2 kPa. Patients then received, in
randomized order, either 1.15% isoflurane or 0.50%
isoflurane and 70% nitrous oxide to achieve a 1-
MAC anaesthetic gas concentration [6]. Twenty
minutes after steady-state exposure to one of the two
gas mixtures, the first CBF velocity (CBFV) meas-
urements were made. A second set of measurements
was made during hyperventilation after PE'COI had
been stable at 4.2 kPa for about 10 min.
For measurements in the awake state, the eight
subjects breathed through a suitable mouthpiece
connected directly to a capnograph (Nellcor 2500).
After baseline measurements, the patients were
requested to hyperventilate to attain an approxi-
mately 20 % reduction in PE'CO . Five minutes after
a steady state was attained, TCD recordings were
performed.
A 2-MHz pulsed Doppler instrumentation system
(TC2-64B, tc-pc interface and its corresponding
data acquisitions software, version 1.2; Eden Medi-
cal Electronics, Uberlingen, Germany) was used for
TCD examinations. The Doppler data were stored
by a personal computer in digital form allowing
post-processing possibilities to be carried out "off
line" at a later time. We chose the middle cerebral
artery (MCA) for examination because of its location
and relatively large diameter which allows easy and
reproducible accessibility for TCD measurements.
The transducer (IMP2, Eden Medical Electronics)
was positioned at the right temporal window using a
circumferential apparatus fixed to the subject's head.
The MCA Doppler signal was located at a depth of
4.5-5.5 cm. Collected Doppler data consisted of
time-mean CBFV, each averaged during four to five
heart beats in expiration.
A carbon dioxide response curve was generated for
each patient. The mean of the two measurements at
different values of PE'COI wa*> used to calculate CBF
reactivity. Global carbon dioxide reactivity was
calculated as an increase and decrease in CBFV per
kPa change in PE'COJ (cm s"1 kPa'1).
Statistical analysis
All data are reported as mean, (SD) and [range] as
appropriate. Physiological values and carbon dioxide
reactivity slopes were compared between groups by
one-way analysis of variance (GLM procedure of
SAS, Release 6.03, SAS Inst. Inc., Cary, NC,
U.S.A., 1988). If significant differences were found,
the Newman-Keuls test was used for further analy-
sis. P < 0.05 was considered statistically significant.
TABLE II . Physiological values (mean (sD))for normovcntilatcd and
hyperventilated patients. fP^co, maintained constant by mechanical
ventilation. Normo. = Normocapma; hypo — hypocapnia; PE'CO
= end-tidal carbon dioxide partial pressure; SpoJ = percutaneous
arterial oxygen saturation; MAP = mean arterial pressure;
HR = heart rate
Normo.
Hypo.
Spo, (%)
Normo.
Hypo.
MAP (mm Hg)
Normo.
Hypo.
HR (beat min"1)
Normo.
Hypo.
Awake
(« = 8)
5.2(0.1)
4.0 (0.3)
98.9(1.0)
99.8 (0.5)
80(6)
82(5)
73(11)
78(9)
Isoflurane
(n = 8)
5-2 (—)t
4.2 (—)+
99.7 (0.5)
99.9 (0.4)
78(10)
78(10)
77(10)
78 (10)
Isofluranc-
nitrous oxide
(n = 8)
5-2 (—)t
4.2 (—)f
99.8 (0.5)
99.9 (0.4)
81(8)
79(7)
75(11)
73(12)
RESULTS
Patient and clinical data were similar for all groups
(table I). Physiological variables did not differ in the
three study groups at baseline or during the study
(table II). In the awake state, a CBFV decrease of
11.24 (1.00) [10.09-12.90] cm s"1 kPa-1 was calcu-
lated (fig. 1A). Carbon dioxide reactivities of the
anaesthetized patients differed from those of the
non-anaesthetized patients (fig. 1B, c). Compared
with the awake group, reactivity to carbon dioxide
was significantly (P < 0.01) greater for the isoflurane
group (14.09 (2.44) [10.40-18.90] cm s"1 kPa"1) and
significantly (P < 0.01) less for the isoflurane-
nitrous oxide group (7.95 (1.32) [6.90-10.50] cm s"1
kPa"1)- The difference in CBFV slopes produced
by hyperventilation with the two anaesthetic
regimens was highly significant (P < 0.001).
DISCUSSION
The purpose of this investigation was to assess
hypocapnia-induced cerebrovascular effects in two
MAC-equivalent anaesthetized groups of healthy
patients. Both regimens, isoflurane alone or iso-
flurane in combination with nitrous oxide, are used
commonly for neurosurgical procedures. Controlled
hyperventilation, which decreases CBF, is routine
during neurosurgery and non-neurological surgery
in patients with reduced intracranial compliance.
Although a linear relationship between arterial
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FIG. 1. Individual slopes ( ) and their means ( ) describing the relationship between end-tidal carbon dioxide
partial pressure (PE'CQ^ and cerebral blood flow velocity (CBFV) for awake patients (A) and for those anaesthetized
with equipotent 1-MAC gas mixtures (isoflurane (B) and isoflurane with nitrous oxide (c)). A: mean of slope = 11.24
(0.95) [10.09-12.90] cm s"1 kPa"1 (n = 8 ) ; B : mean of slope = 14.09(2.44) [10.40-18.90] cm s"1 kPa"1 (n = 8);c: mean
of slope = 7.95 (1.32) [6.90-10.50] an s"1 kPa"1 (n = 8) (mean (SD) [range]). Significant intergroup differences
(ANOVA, Newman-Keuls test): isoflurane (B) VS awake (A), P < 0.01; isoflurane (B) VS isonurane-nitrous oxide (C),
P < 0.001; isoflurane-nitrous oxide (c) vs awake (A), P < 0.01.
carbon dioxide and CBF has been described [7], the
influence of anaesthetic agents or combinations of
anaesthetic agents on CBF sensitivity to carbon
dioxide in humans is not well documented.
The effects of isoflurane on CBF and cerebral
metabolism suggest that this agent may be more
appropriate for use in neurosurgery than other
volatile anaesthetics [5, 8]. Nitrous oxide is a com-
mon component of general anaesthesia; moreover, it
has been used in neuroanaesthetic procedures for
decades. Its use makes it possible to reduce the
required concentration of volatile anaesthetic, and its
potential cerebrovascular effects are believed to be
blocked by some degree of hypocapnia. However, an
increasing number of studies in animals and in
humans suggest that nitrous oxide may have sub-
stantial effects on CBF [9, 10]. This is particularly
true when the gas is added to a volatile anaesthetic.
In several studies, using various methods and
species, the interactive effect of nitrous oxide and
volatile anaesthetics has been shown to be a sub-
stantial increase in CBF [11-15].
Reactivity of the cerebral vasculature to carbon
dioxide is commonly used to evaluate cerebro-
vascular integrity. It is assumed that CBF varies
almost linearly with arterial carbon dioxide concen-
tration changes between 2.5 and 8.0 kPa [7, 16]. The
present CBFV results following a carbon dioxide
challenge in the awake state corroborate TCD results
published elsewhere [17]. Our results are also in
accord with carbon dioxide reactivity of CBF
determined by a xenon-133 washout technique [18].
In the isoflurane-anaesthetized patients, TCD values
demonstrated a significantly enhanced carbon di-
oxide reactivity compared with awake patients. How-
ever, this increase in reactivity was not found in
patients who received the equi-MAC concentration
of isoflurane in nitrous oxide; reactivity in the latter
group was significantly less than in the awake group.
The mechanism by which volatile agents, in-
cluding nitrous oxide, alter the slope of the CO2—
CBF relation is unknown. Cerebral reactivity to
carbon dioxide is thought to be mediated by carbon
dioxide-related changes in extracellular pH and it is
not clear why volatile anaesthetics should alter this
interaction. The reasons for the attenuation of the
carbon dioxide response curve in the isoflurane-
nitrous oxide group remain speculative. They may
be related to the underlying mechanism by which
nitrous oxide produces its effects: it may have a
direct relaxant effect on vascular smooth muscle or
may stimulate cerebral metabolism, with an associ-
ated increase in CBF. The effects of volatile
anaesthetics on CBF are mediated to large extent by
dieir effects on cerebral metabolism, and it may be
postulated that perturbation of this relationship by
nitrous oxide might increase CBF. It is important to
note that nitrous oxide is not physiologically inert
and, despite hyperventilation, may have striking
effects on CBFV and CBF. Therefore it would seem
prudent, upon encountering a "tight" brain during
operation, to discontinue the use of nitrous oxide.
Several aspects of the methods used in the present
study, particularly the validity of measuring MCA
flow velocity as an index of CBF, deserve comment.
This non-invasive technique of measuring CBF was
first introduced in 1982 [19]. The main assumption
is that the calibre of the MCA remains constant
throughout the measurement. A change in vessel
diameter could have a significant effect on flow
velocity; however, angiographic evidence suggests
that the calibres of the large basal arteries remain
constant during changes in PE'CO, [20]. Moreover,
measurement of cerebrovascular reactivity to changes
in PE'COI using TCD technology has yielded results
similar to those obtained with direct measurements
of CBF [21]. When the calibre of the MCA remains
constant, changes in MCA flow velocity are pro-
portional to the CBF. Nevertheless, it should be
emphasized that there is considerable variation in the
diameter of the MCA; this variability causes dif-
ferences in blood flow velocity between individuals,
thus precluding comparison of absolute flow values.
Within a given individual, however, simultaneous
measurements of CBF (determined with the xenon-
133 technique) and MCA flow velocity have demon-
strated a good correlation between proportional
changes in these two variables in response to
changing concentrations of carbon dioxide [17].
When the effects of anaesthesia on CBF are being
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examined, the site of the measurement must be taken
into consideration. The MCA carries about 80% of
the flow volume received by the cerebral hemisphere
[22]. Hence, changes in MCA flow velocity should
be representative of general changes in brain per-
fusion. Comparative studies have demonstrated that
individual changes in MCA CBFV reflect con-
comitant changes in internal carotid artery volume
flow as determined by ipsilateral electromagnetic
measurements [23].
Additional considerations when CBFV data are
interpreted include arterial pressure and cerebral
perfusion pressure, in addition to drug effects other
than those related to anaesthetics. In the present
study, arterial pressure was maintained at the same
value during all experiments. In addition, auto-
regulation may be expected to be unaffected at a 1-
MAC level of anaesthesia [24]. The pharmacokinetic
profile of the short-acting i.v. anaesthetic propofol,
used in this study, makes it unlikely that this drug
exerted an appreciable effect on the cerebral vascu-
lature. Alfentanil does not affect cerebral haemo-
dynamics [25]. To our knowledge, there are no data
on atracurium and cerebral circulation. However, as
with the non-depolarizing neuromuscular blocker,
tubocurarine [26], it is not likely that atracurium
influences CBF. Thus it is unlikely that these factors
might have contributed to our cerebrovascular
findings and it seems reasonable to conclude that
CBF was affected only by the anaesthetics and by
1 h
 CO,-
Arterial blood-gas estimation during CBF de-
termination is a critical requirement for quantitative
interpretation of the results. In this study, we used
PE'COI as an estimate of arterial carbon dioxide
tension. Recent data examining the correlation
between arterial and PE'COJ estimations and the
relationship between the two methods to calculate
cerebrovascular carbon dioxide reactivity demon-
strated that the true slope of CBF response to
changes in carbon dioxide tension can be estimated
reliably from non-invasive measurement of PE'CO
[27].
In conclusion, there are alterations in cerebro-
vascular responsiveness to changes in carbon dioxide
concentrations that occur during anaesthetic pro-
cedures. The cerebrovascular reactivity to carbon
dioxide is increased using 1 MAC isoflurane anaes-
thesia and attenuated using 1 MAC isoflurane in
nitrous oxide anaesthesia. Thus hyperventilation is
more likely to affect CBF during isoflurane than
during MAC-equivalent isoflurane in nitrous oxide
anaesthesia. The use of nitrous oxide, as opposed to
an increased dose of a volatile anaesthetic, has no
advantage with respect to minimizing anaesthetic-
induced increases in CBFV and CBF.
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